Clinical Trials Browser

Withdrawn × Lung Neoplasms × Bortezomib × Clear all

NCT00313690 2014-05-21

Cancer Treatment Followed by Surgery for Early Stage Non-small Cell Lung Cancer

Phase 1/2 Withdrawn

Lung Neoplasms

NCT00411593 2012-02-08

Phase I-II for Patients With Recurrent or Refractory Non-small Cell Lung Cancer (NSCLC)

Phase 1/2 Withdrawn

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms